Oral Dose Development of Macromolecules
Summary: Today, a majority of macromolecule doses are delivered in traditional but invasive injectable formats, which often results in poor patient compliance and therefore is not the most suitable route for long term treatment. Although oral delivery has always been preferred, there are a variety of development challenges faced by formulation scientists. This article presents the new approach, OptiForm® Solution Suite Bio by Catalent Pharma to optimize oral dose development for macromolecules.